Home Clinical Topics FDA announces plans for review of its opioid policies

FDA announces plans for review of its opioid policies

On Feb. 4, the Food and Drug Administration (FDA) announced it is planning to assess the agency’s approach to opioid medications, in response to the opioid abuse epidemic. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here